Research Peptides in Erie, PA

Shipping research peptides to Erie

Research groups in Erie receive third-party-tested vials with fast domestic dispatch. Peptides Factory Direct ships the full catalog to Erie and across Pennsylvania; material arrives as a refrigerator-stable powder ready for reconstitution, and each Erie lot carries a 99%+ purity target with a COA on request and a tracked lot number.

Research peptide categories shipped to Erie

Erie researchers can order across all seven research categories in the catalog. The table below maps each category to what it is studied for and example compounds.

Research peptides Erie researchers request most

Below are the research peptides Erie laboratories most often order. Each summary reflects the published research literature and is provided for laboratory context only, and every compound is research-use-only and is not for human or animal consumption.

Epithalon (Epitalon) research

Epithalon (Epitalon) is a synthetic tetrapeptide based on a naturally occurring pineal peptide. It is one of the most-cited peptides in longevity research because of its reported association with telomerase activity and telomere length in study models.

Research mechanism. Epithalon research focuses on potential activation of telomerase - the enzyme that maintains telomeres - and on pineal/melatonin-axis regulation, both of which are longevity-research variables.

Telomere and longevity research. The central research theme, studying telomerase and cellular-aging endpoints.

Pineal / circadian research. Examined for melatonin-axis and sleep-regulation variables.

Cellular-aging models. Used in broad aging-research designs.

How it compares. Epithalon is studied for telomere/longevity endpoints specifically, distinguishing it from immune-focused Thymosin Alpha-1 and cognitive peptides.

Research pairings. Studied as a standalone longevity peptide, sometimes alongside Thymosin Alpha-1 in aging-research designs.

Reference research values. Research references commonly cite 1 mg daily across a 10-day cycle, repeated every 3-6 months. Reference values only.

Full Epithalon research profile → · Anti-Aging & Longevity peptides

Ovagen (Organ Bioregulator) research

Ovagen is a peptide bioregulator from the Khavinson family, studied for reproductive and organ tissue-support concepts in research models. Peptide bioregulators are investigated for tissue-specific normalization of gene expression and protein synthesis.

Research mechanism. Ovagen research centers on tissue-specific peptide bioregulation - the concept that short peptides can support normal function and protein synthesis in their target organ tissue - within reproductive and organ-support research models.

Reproductive-tissue research. Studied for reproductive and organ tissue-support endpoints in models.

Organ-support research. Examined in bioregulator research focused on tissue normalization concepts.

Longevity bioregulator research. Investigated within the broader Khavinson bioregulator research framework.

How it compares. Ovagen is an organ/reproductive-tissue bioregulator, distinct from the vascular bioregulator Vesugen and the neuro bioregulator Pinealon.

Research pairings. Studied alongside other Khavinson bioregulators (Epithalon, Vesugen, Pinealon) in organ-support research designs.

Reference research values. Research references commonly cite 2-5 mg daily in short-course bioregulator study cycles. Reference values only - not for human or animal use.

Full Ovagen research profile → · Specialty peptides

CJC-1295 (with or without DAC) research

CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It is studied in two forms: "no DAC" (also called Mod GRF 1-29), which is short-acting, and "with DAC" (Drug Affinity Complex), which binds albumin for a markedly longer half-life in research models.

Research mechanism. CJC-1295 research focuses on stimulation of the pituitary to release growth hormone in pulses. The DAC version extends the active window, while the no-DAC version produces a sharper, shorter pulse often studied alongside a GHRP such as Ipamorelin for synergistic release.

Growth-hormone release research. The central research theme is endogenous GH-pulse stimulation and the comparison of DAC vs no-DAC kinetics.

Body-composition models. It is studied for downstream effects on muscle and fat metabolism in research models.

GHRH + GHRP synergy studies. CJC-1295 + Ipamorelin is one of the most-studied research pairings for amplified GH pulses.

How it compares. The DAC form trades fewer administrations for a longer, flatter profile; the no-DAC form is studied for sharper, more physiologic pulses. Choice depends on the research kinetics of interest.

Research pairings. CJC-1295 (no DAC) + Ipamorelin is the canonical research pairing; the GHRH analog and the GHRP are reported to act through complementary receptors.

Reference research values. Research references commonly cite 200-300 mcg of the no-DAC form before rest periods on a 5-7 day schedule, or 1-2 mg of the DAC form one to two times weekly. Reference values only.

Full CJC-1295 research profile → · Growth Hormone & Muscle peptides

AOD 9604 (HGH Fragment 176-191) research

AOD 9604 is a modified fragment (residues 176-191) of human growth hormone, representing the region associated with fat metabolism. It is studied because it isolates the lipolytic portion of GH without the growth-signaling or glucose effects of the whole hormone.

Research mechanism. AOD 9604 research focuses on stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis without acting on the IGF-1 axis or blood glucose - the defining research feature.

Lipolysis research. Studied specifically for fat-metabolism endpoints in models.

Metabolic models without glucose effect. Useful where researchers want fat signaling isolated from blood-sugar variables.

Stubborn-fat research. Examined in models of resistant adipose tissue.

How it compares. Unlike GLP-1 peptides that act on appetite, AOD 9604 isolates the fat-metabolism portion of GH and does not affect blood sugar - a distinct research mechanism.

Research pairings. Sometimes studied alongside GH-secretagogues in metabolic research designs.

Reference research values. Research references commonly cite 300-600 mcg daily (often modeled in a fasted window) over 12-16 week study periods. Reference values only.

Full AOD 9604 research profile → · Fat Loss & Weight Management peptides

PT-141 (Bremelanotide) research

PT-141 (Bremelanotide) is a synthetic melanocortin-receptor agonist derived from Melanotan II. It is studied for sexual-function endpoints through a central-nervous-system mechanism rather than a vascular one.

Research mechanism. PT-141 research focuses on activation of melanocortin receptors (notably MC4R) in the central nervous system, which is the distinguishing feature versus vascular mechanisms studied for other compounds.

Libido / sexual-function research. Studied for arousal endpoints in both male and female models via CNS signaling.

Melanocortin-pathway research. A model compound for MC4R signaling studies.

Centrally-mediated research. Used where a central rather than vascular mechanism is the variable.

How it compares. Unlike vascular-pathway compounds, PT-141 acts centrally; unlike Melanotan I/II it is studied primarily for sexual-function rather than tanning endpoints.

Research pairings. Generally studied as a standalone melanocortin agonist.

Reference research values. Research references commonly cite 1-2 mg administered 45-90 minutes before the modeled endpoint, used as-needed rather than daily. Reference values only.

Full PT-141 research profile → · Sexual Health & Tanning peptides

Gonadorelin (GnRH) research

Gonadorelin is a synthetic form of gonadotropin-releasing hormone (GnRH). It is studied for its role in stimulating the pituitary to release luteinizing hormone and follicle-stimulating hormone in a pulsatile pattern.

Research mechanism. Gonadorelin research focuses on pulsatile GnRH-receptor activation - the natural rhythm matters, so frequent administration is modeled to mimic endogenous pulses.

Reproductive-hormone research. Studied for LH/FSH stimulation endpoints.

Pulsatile-signaling research. Examined for the importance of pulse frequency in models.

Hormone-axis maintenance research. Studied in models of endogenous hormone production.

How it compares. Gonadorelin is GnRH itself; Kisspeptin acts upstream of it, and HCG mimics LH downstream - three distinct points in the hormone axis.

Research pairings. Generally studied as a standalone GnRH peptide.

Reference research values. Research references commonly cite 100-200 mcg two to three times daily in pulsatile designs. Reference values only.

Full Gonadorelin research profile → · Specialty peptides

Tirzepatide (dual GLP-1/GIP agonist) research

Tirzepatide is a dual agonist that activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. It is one of the most-studied modern metabolic research peptides because it engages two incretin pathways at once.

Research mechanism. Tirzepatide research examines combined GLP-1 and GIP signaling on insulin response, satiety, and energy handling, with the dual-pathway mechanism the central research distinction.

Weight-management research. Studied for body-weight endpoints via dual incretin signaling.

Glucose-metabolism research. Examined for combined GLP-1/GIP metabolic effects.

Comparative incretin studies. Frequently compared with semaglutide.

How it compares. Tirzepatide adds GIP activity on top of GLP-1, which is the defining contrast with single-pathway semaglutide in research.

Research pairings. Studied as a standalone dual-agonist model or compared with semaglutide.

Reference research values. Research references describe a titration model from 2.5 mg up to 15 mg weekly over several weeks. Reference values only.

Full Tirzepatide research profile → · Fat Loss & Weight Management peptides

Semaglutide (GLP-1 agonist) research

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with a long half-life. It is among the most-studied metabolic research peptides because of the extensive GLP-1 literature on glucose handling and satiety signaling.

Research mechanism. Semaglutide research centers on GLP-1-receptor activation: enhanced glucose-dependent insulin signaling, slowed gastric emptying, and central satiety pathways. These endpoints are studied in metabolic and weight-related research models.

Weight-management research. The dominant research theme is appetite and body-weight modeling via GLP-1 signaling.

Glucose-metabolism research. Studied for glucose-dependent insulin and metabolic endpoints.

Comparative GLP-1 studies. Frequently compared with Tirzepatide in dual-pathway research.

How it compares. Semaglutide is a single-pathway GLP-1 agonist; Tirzepatide is a dual GLP-1/GIP agonist. The two are the central comparison in modern metabolic-peptide research.

Research pairings. In research it is studied as a standalone GLP-1 model or compared head-to-head with Tirzepatide.

Reference research values. Research references describe a titration model from 0.25 mg up to 2.4 mg weekly over several weeks. Reference values only.

Full Semaglutide research profile → · Fat Loss & Weight Management peptides

N-Acetyl Semax Amidate (potent Semax analog) research

N-Acetyl Semax Amidate is a modified version of Semax with acetylation and amidation that the literature associates with greater potency and a longer active window in cognitive-research models.

Research mechanism. Like Semax, it is studied for BDNF and nerve-growth-factor signaling and monoamine modulation, with the modifications extending stability and duration in models.

Advanced cognitive research. Studied for focus, learning, and mental-clarity endpoints with a longer duration.

Neuroprotection research. Examined in neural-stress and recovery models.

BDNF-signaling research. A more stable model compound for neurotrophic studies.

How it compares. It is studied as more potent and longer-lasting than standard Semax, suited to demanding cognitive-research models.

Research pairings. Studied alongside Selank in cognitive-research designs.

Reference research values. Research references commonly cite 300-600 mcg daily across 2-4 week cycles. Reference values only.

Full N-Acetyl Semax Amidate research profile → · Cognitive & Neurological peptides

GHK-Cu (Copper Peptide) research

GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine bound to copper). It is one of the most studied peptides in regenerative and dermatological research because of its role in copper transport and remodeling of the extracellular matrix.

Research mechanism. Research associates GHK-Cu with stimulation of collagen and elastin synthesis, antioxidant and anti-inflammatory signaling, and modulation of genes involved in tissue remodeling. The injectable form is studied separately from topical cosmetic applications.

Skin and tissue regeneration research. GHK-Cu is studied for wound-model healing, extracellular-matrix remodeling, and collagen synthesis.

Hair-follicle research. It appears frequently in hair-growth and follicle-signaling research models.

Anti-inflammatory and antioxidant studies. Its copper-transport role is studied for redox and inflammation endpoints.

How it compares. GHK-Cu targets skin, hair, and matrix research where BPC-157 and TB-500 target connective and muscle tissue, so it covers a distinct research niche.

Research pairings. In regenerative research GHK-Cu is sometimes paired with BPC-157 or TB-500 to model both structural and dermal repair.

Reference research values. Research references commonly cite 1-2 mg administered 3-5 times per week. Reference values only.

Full GHK-Cu research profile → · Healing & Recovery peptides

Tesamorelin (GHRH analog) research

Tesamorelin is a stabilized analog of growth-hormone-releasing hormone studied for its reported effect on visceral adipose tissue - the fat surrounding internal organs - in metabolic research models.

Research mechanism. Tesamorelin stimulates endogenous GH release like other GHRH analogs, with research focused specifically on visceral-fat endpoints rather than subcutaneous fat.

Visceral-fat research. Studied specifically for visceral adipose tissue endpoints.

Metabolic-health models. Examined for broader metabolic-syndrome research variables.

GHRH-axis research. Used as a GHRH analog in GH-release studies.

How it compares. Tesamorelin is studied for visceral fat specifically, distinguishing it from AOD 9604 (general lipolysis) and the GLP-1 peptides (appetite).

Research pairings. Studied as a standalone GHRH analog in metabolic research.

Reference research values. Research references commonly cite 1-2 mg daily. Reference values only.

Full Tesamorelin research profile → · Fat Loss & Weight Management peptides

HCG (Human Chorionic Gonadotropin) research

HCG (human chorionic gonadotropin) is a glycoprotein hormone that mimics luteinizing hormone. It has a well-established research profile and is studied for its downstream effects on gonadal hormone production.

Research mechanism. HCG research focuses on LH-receptor activation, stimulating gonadal tissue in research models - the downstream counterpart to upstream GnRH and Kisspeptin signaling.

Reproductive-hormone research. Studied for gonadal-hormone and fertility endpoints.

LH-analog research. A model compound for LH-receptor studies.

Hormone-axis research. Examined in models of endogenous hormone support.

How it compares. HCG mimics LH downstream, while Gonadorelin and Kisspeptin act upstream in the same axis.

Research pairings. Studied alongside GnRH peptides in hormone-axis research designs. Banned by WADA - relevant for sports-science researchers.

Reference research values. Research references commonly cite 250-500 IU two to three times weekly. Reference values only.

Full HCG research profile → · Specialty peptides

Adamax (Nootropic Peptide Analog) research

Adamax is a synthetic nootropic peptide analog discussed in neuroprotection and cognitive research. It sits in the nootropic-peptide family alongside compounds like Semax and Selank, and is examined for neurotrophic and neuroprotective signaling in research models.

Research mechanism. Adamax research focuses on neurotrophic and neuroprotective signaling - including interest in BDNF-related pathways and neuro-recovery endpoints - as a short-acting nootropic peptide analog.

Cognitive / nootropic research. Studied for attention, memory, and cognitive-performance endpoints in models.

Neuroprotection research. Examined for neuroprotective and neurotrophic signaling.

Neuro-recovery research. Investigated in recovery-oriented neurological research designs.

How it compares. Adamax is a synthetic nootropic analog, distinct from the bioregulator Pinealon and the well-characterized Semax/Selank nootropics, and is treated as a more advanced research compound.

Research pairings. Studied alongside other nootropic peptides such as Semax and Selank in cognitive-research designs.

Reference research values. Research references commonly cite 250-1000 mcg daily depending on the cognitive-research objective, often in an intranasal model. Reference values only - not for human or animal use.

Full Adamax research profile → · Cognitive & Neurological peptides

GHRP-2 (Growth Hormone Releasing Peptide-2) research

GHRP-2 is a synthetic hexapeptide growth-hormone secretagogue, studied as a middle ground between GHRP-6 (strong appetite signaling) and Ipamorelin (selective and clean).

Research mechanism. GHRP-2 activates the GH-secretagogue receptor for GH release, with a reportedly smaller appetite response than GHRP-6 and somewhat more than Ipamorelin in research models.

GH-release research. A potent GHRP for growth-hormone-pulse studies.

Body-composition models. Studied for downstream metabolic endpoints.

GHRH synergy research. Paired with CJC-1295 in stacking studies.

How it compares. GHRP-2 is studied as a balance between GHRP-6 potency/appetite and Ipamorelin selectivity.

Research pairings. GHRP-2 + CJC-1295 is a common research pairing; prolactin is monitored in models.

Reference research values. Research references commonly cite 100-300 mcg two to three times daily. Reference values only.

Full GHRP-2 research profile → · Growth Hormone & Muscle peptides

Research applications studied in Erie

• Telomere and longevity research (Epithalon). The central research theme, studying telomerase and cellular-aging endpoints.
• Reproductive-tissue research (Ovagen). Studied for reproductive and organ tissue-support endpoints in models.
• Growth-hormone release research (CJC-1295). The central research theme is endogenous GH-pulse stimulation and the comparison of DAC vs no-DAC kinetics.
• Lipolysis research (AOD 9604). Studied specifically for fat-metabolism endpoints in models.
• Libido / sexual-function research (PT-141). Studied for arousal endpoints in both male and female models via CNS signaling.

How Erie researchers order and store material

Ordering for a Erie lab is done in the Peptides Factory Direct portal, with one-time or recurring options and a checkout confirmation of laboratory research use. Material ships to Erie as a lyophilized powder for refrigerated storage; after reconstitution keep it cold and use within the standard research window. Erie researchers remain responsible for compliance with applicable law, and nothing supplied is for human or animal consumption. Open the order portal.

Why Erie researchers choose Peptides Factory Direct

Research buyers in Erie choose Peptides Factory Direct for one reason: verifiable quality. Every Erie shipment carries a 99%+ purity target, a Certificate of Analysis on request, full lot tracking, and reference documentation for each compound. Fast domestic dispatch gets stable vials to Erie labs without delay, and pricing and standards match every other US research address.

Nearby Pennsylvania research areas we ship to

Frequently asked questions

All Pennsylvania cities · All states · Research guides

External references: Pennsylvania (Wikipedia) · U.S. Census Bureau